Finance

Lists
LH:NYSE
Labcorp Holdings Inc
US$308,65
+0,05%
(+0,16) 1D
US$308,60
-0,02% (-0,050)
Pre-market
Closed: 5 ຕ.ລ., 16 ໂມງ 0 ນາທີ 04 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LH...
Open
US$308,08
High
US$309,78
Low
US$305,84
Mkt. cap
25,03 ຕື້
Avg. vol.
767,06 ພັນ
Volume
2,11 ພັນ
Dividend
0,93%
Quarterly dividend
US$0,72
Ex-dividend date
29 ພ.ພ. 2026
P/E ratio
25,52
52-wk high
US$341,80
52-wk low
US$244,52
EPS
US$12,09
Beta
0,88
Shares outstanding
81,10 ລ້ານ
No. of employees
71 ພັນ
Open
US$308,08
High
US$309,78
Low
US$305,84
Mkt. cap
25,03 ຕື້
Avg. vol.
767,06 ພັນ
Volume
2,11 ພັນ
Dividend
0,93%
Quarterly dividend
US$0,72
Ex-dividend date
29 ພ.ພ. 2026
P/E ratio
25,52
52-wk high
US$341,80
52-wk low
US$244,52
EPS
US$12,09
Beta
0,88
Shares outstanding
81,10 ລ້ານ
No. of employees
71 ພັນ
News stories
From web sources and news partners
Profile
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
About Labcorp Holdings Inc
CEOAdam H. Schechter
Employees71 ພັນ
Founded1978
HeadquartersBurlington, ນອດ ຄາໂຣໄລນາ, ສະຫະລັດ
SectorHealth care provider
Analyst ratings
Based on 13 analysts giving stock ratings to LH in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for LH in the last 3 months.
Highest
Current US$308,65
US$380,00 (+23,12%)
Average
US$343,50 (+11,29%)
Lowest
US$306,00 (-0,86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Cherny
Leerink Partners
Buy
Reiterated
-
-
09/23/2026
David S Macdonald
Truist Financial
Buy
Maintained
US$365,00
+18,3%
09/21/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
US$340,00
+10,2%
09/11/2026
Kevin Caliendo
UBS
Buy
Maintained
US$380,00
+23,1%
09/11/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
09/11/2026
Luke Sergott
Barclays
Hold
Maintained
US$330,00
+6,9%
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
-
-
08/26/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
US$355,00
+15%
08/10/2026
David Westenberg
Piper Sandler
Hold
Reiterated
US$309,00
+0,1%
08/04/2026
Pito Chickering
Deutsche Bank
Hold
Reiterated
US$306,00
-0,9%
07/31/2026
Erin Wright
Morgan Stanley
Buy
Maintained
US$338,00
+9,5%
07/31/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
US$352,00
+14%
07/31/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
US$360,00
+16,6%
07/30/2026
David Toung
Argus Research
Buy
Maintained
US$310,00
+0,4%
06/02/2026
Unknown Analyst
Mizuho Securities
Buy
Reiterated
US$320,00
+3,7%
05/27/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
04/30/2026
Last report
30 ກ.ລ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$4,99 / US$4,77
+4,65%beat
Revenue / Est. (USD)
3,73 ຕື້ / 3,71 ຕື້
+0,47%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
3,56 ຕື້
3,52 ຕື້
3,54 ຕື້
3,73 ຕື້
Cost of goods sold
2,54 ຕື້
2,52 ຕື້
2,52 ຕື້
2,62 ຕື້
Cost of revenue
2,54 ຕື້
2,52 ຕື້
2,52 ຕື້
2,62 ຕື້
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
552,40 ລ້ານ
549,70 ລ້ານ
551,00 ລ້ານ
577,20 ລ້ານ
Operating expense
621,90 ລ້ານ
622,30 ລ້ານ
626,60 ລ້ານ
655,30 ລ້ານ
Total operating expenses
3,16 ຕື້
3,14 ຕື້
3,15 ຕື້
3,27 ຕື້
Operating income
403,20 ລ້ານ
370,90 ລ້ານ
387,20 ລ້ານ
456,70 ລ້ານ
Other non operating income
700,00 ພັນ
1,90 ລ້ານ
-600,00 ພັນ
-3,50 ລ້ານ
EBT including unusual items
337,00 ລ້ານ
190,60 ລ້ານ
319,70 ລ້ານ
386,40 ລ້ານ
EBT excluding unusual items
341,30 ລ້ານ
315,20 ລ້ານ
333,20 ລ້ານ
391,50 ລ້ານ
Income tax expense
75,50 ລ້ານ
25,70 ລ້ານ
41,70 ລ້ານ
87,30 ລ້ານ
Effective tax rate
22,40%
13,48%
13,04%
22,59%
Other operating expenses
-
-
-
-
Net income
261,10 ລ້ານ
164,70 ລ້ານ
277,80 ລ້ານ
298,70 ລ້ານ
Net profit margin
7,33%
4,68%
7,85%
8,01%
Earnings per share
4,18
4,07
4,25
4,99
Interest and investment income
3,50 ລ້ານ
3,50 ລ້ານ
12,20 ລ້ານ
5,60 ລ້ານ
Interest expense
-56,00 ລ້ານ
-55,00 ລ້ານ
-55,10 ລ້ານ
-61,10 ລ້ານ
Net interest expenses
-52,50 ລ້ານ
-51,50 ລ້ານ
-42,90 ລ້ານ
-55,50 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
574,20 ລ້ານ
549,40 ລ້ານ
560,50 ລ້ານ
635,70 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
ແອັບຂອງ Google